# Biotech Daily Digest ‚Äî 2025-09-30

**61 items from 3 sources**

## Summary by Source

- Endpoints News: 9 items
- Fierce Biotech: 7 items
- arXiv q-bio: 45 items


## Endpoints News

- **[Barinthus‚Äô reverse merger with private biotech; Sutro to lay off 33% of employees](https://endpoints.news/barinthus-reverse-merger-with-private-biotech-sutro-to-lay-off-33-of-employees/)**  
  _Tue, 30 Sep 2025 14:36:27 +0000_  
  Plus, news about Ocular Therapeutix, Kardigan, ARS Pharmaceuticals, Full-Life Technologies, Orion, Novo Nordisk, Nxera Pharma and UniQure:

 üìà Barinthus Biotherapeutics inks reverse merger: The UK biotech will hand its Nasdaq spot to

- **[Metsera‚Äôs new obesity data create side effect and efficacy questions for Pfizer to answer](https://endpoints.news/metseras-new-obesity-data-create-side-effect-and-efficacy-questions-for-pfizer-to-answer/)**  
  _Tue, 30 Sep 2025 11:31:58 +0000_  
  Pfizer‚Äôs back in obesity. Or is it?

 The hotly-awaited Phase 2b readout of the long-acting GLP-1 shot developed by Metsera, the biotech Pfizer said it would buy for $4.9 billion last week ...

- **[AnaptysBio plans to split its pipeline from its royalty assets into two publicly traded companies](https://endpoints.news/anaptysbio-plans-to-split-its-pipeline-from-its-royalty-assets-into-two-publicly-traded-companies/)**  
  _Tue, 30 Sep 2025 11:29:18 +0000_  
  AnaptysBio wants to split into two companies to see if its pipeline and royalty assets will get more appreciation from investors if they stand alone.

 The San Diego biotech said Monday ...

- **[Opus says gene therapy for ultra-rare disease boosted vision in teens](https://endpoints.news/opus-says-gene-therapy-for-ultra-rare-disease-boosted-vision-in-teens/)**  
  _Tue, 30 Sep 2025 11:00:13 +0000_  
  Opus Genetics reported that its gene therapy helped partially restore vision in one eye for a small cohort of teens with a rare congenital form of blindness called Leber congenital amaurosis.

 One of the three ...

- **[Star gets $125M Series D as it begins Phase 3 in bleeding disorders](https://endpoints.news/star-gets-125m-series-d-as-it-begins-phase-3-in-bleeding-disorders/)**  
  _Tue, 30 Sep 2025 10:30:56 +0000_  
  Star Therapeutics patched together a $125 million Series D in what it thinks is pharma's next big therapeutic category.

 The South San Francisco startup expects the funds to add a few years of runway and ...

- **[GSK CEO Emma Walmsley on her exit, running the company and more](https://endpoints.news/gsk-ceo-emma-walmsley-on-her-exit-running-the-company-and-more/)**  
  _Mon, 29 Sep 2025 18:00:31 +0000_  
  On Monday, GSK announced that CEO Emma Walmsley will step down and chief commercial officer Luke Miels will replace her. Walmsley joined the company in 2010, ran its consumer division and then ...

- **[Genmab CEO on his yearslong interest in Merus](https://endpoints.news/genmab-ceo-on-his-yearslong-interest-in-merus/)**  
  _Mon, 29 Sep 2025 17:00:00 +0000_  
  Genmab made one of the splashiest European biopharma acquisitions in recent memory on Monday morning, when it said it would buy antibody maker Merus for $8 billion in cash.

 Endpoints News caught ...

- **[White House deadline brings flurry of pharma price cutdowns](https://endpoints.news/white-house-deadline-brings-flurry-of-pharma-price-cutdowns/)**  
  _Mon, 29 Sep 2025 16:20:56 +0000_  
  Several drugmakers announced new discounts and direct-to-consumer offerings on Monday as they run up against President Donald Trump‚Äôs deadline for pharma companies to bring their US drug prices in line with fellow nations.

 AbbVie, Novartis ...

- **[Enanta's RSV treatment fails Phase 2b study, but positives seen in subgroups](https://endpoints.news/enantas-rsv-treatment-fails-phase-2b-study-but-positives-seen-in-subgroups/)**  
  _Mon, 29 Sep 2025 15:07:30 +0000_  
  Enanta Pharmaceuticals revealed on Monday that a Phase 2b study for an RSV treatment in high-risk adults missed its primary endpoint. But executives believe there‚Äôs a path forward, and investors seem to agree.

 In the ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/biotech/opus-sets-sights-fda-talks-after-posting-pediatric-gene-therapy-data" hreflang="en">Opus sets sights on FDA talks after posting pediatric gene therapy data</a>](https://www.fiercebiotech.com/biotech/opus-sets-sights-fda-talks-after-posting-pediatric-gene-therapy-data)**  
  _Sep 30, 2025 8:40am_  
  Opus Genetics has shared data on its gene therapy in children with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps for the program.

- **[<a href="https://www.fiercebiotech.com/biotech/pfizers-new-prize-metsera-touts-141-weight-loss-lead-glp-1-drug" hreflang="en">Pfizer's new prize Metsera touts 14% weight loss, 'class-leading tolerability' for lead GLP-1 drug</a>](https://www.fiercebiotech.com/biotech/pfizers-new-prize-metsera-touts-141-weight-loss-lead-glp-1-drug)**  
  _Sep 30, 2025 5:56am_  
  The GLP-1 agonist at the center of Pfizer‚Äôs upfront $4.9 billion buyout of Metsera last week has been tied to 14.1% weight loss at 28 weeks as well as ‚Äúpotentially class-leading tolerability,‚Äù according to the biotech.

- **[<a href="https://www.fiercebiotech.com/biotech/star-therapeutics-collects-shiny-125m-funding-boost-push-bleeding-disorder-prospect-orbit" hreflang="en">Star Therapeutics collects shiny $125M funding boost to push bleeding disorder prospect into orbit </a>](https://www.fiercebiotech.com/biotech/star-therapeutics-collects-shiny-125m-funding-boost-push-bleeding-disorder-prospect-orbit)**  
  _Sep 29, 2025 4:23pm_  
  Star Therapeutics will use the financing to support its pipeline of bleeding disorder candidates, including phase 3 von Willebrand disease treatment VGA039.

- **[<a href="https://www.fiercebiotech.com/biotech/sutro-loses-3rd-workforce-adc-biotechs-2nd-round-layoffs-year" hreflang="en">Sutro loses 3rd of workforce in ADC biotech's 2nd round of layoffs this year</a>](https://www.fiercebiotech.com/biotech/sutro-loses-3rd-workforce-adc-biotechs-2nd-round-layoffs-year)**  
  _Sep 30, 2025 4:17am_  
  The layoffs aren‚Äôt letting up at Sutro Biopharma. After halving the antibody-drug conjugate biotech‚Äôs head count in the spring, the company is waving goodbye to a third of its remaining workforce in the fall.

- **[<a href="https://www.fiercebiotech.com/biotech/biolinerx-forges-joint-venture-develop-cancer-candidate-norwegian-biotech" hreflang="en">BioLineRx forges partnership with Norwegian biotech to advance cancer candidate</a>](https://www.fiercebiotech.com/biotech/biolinerx-forges-joint-venture-develop-cancer-candidate-norwegian-biotech)**  
  _Sep 29, 2025 11:06am_  
  Israeli drug developer BioLineRx is heading north to help Norwegian biotech Hemispherian develop its lead cancer asset in a joint venture, the partners announced in a Sept. 29 release.

- **[<a href="https://www.fiercebiotech.com/biotech/enanta-sees-rsv-drug-fail-phase-2b-finds-positives-secondaries-and-subgroups" hreflang="en">Enanta sees RSV drug fail phase 2b's primary endpoint but finds positives in secondaries and subgroup</a>](https://www.fiercebiotech.com/biotech/enanta-sees-rsv-drug-fail-phase-2b-finds-positives-secondaries-and-subgroups)**  
  _Sep 29, 2025 7:46am_  
  A phase 2b trial of Enanta Pharmaceuticals‚Äô respiratory syncytial virus drug candidate has missed its primary endpoint. But with other analyses generating signs of efficacy, the biotech made the case that the data support further development of the oral, direct-acting antiviral zelicapavir.

- **[<a href="https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025" hreflang="en">Fierce Biotech Layoff Tracker 2025: IO lays off 50% of employees; Heidelberg reduces headcount by 75%</a>](https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2025)**  
  _Dec 23, 2024 11:52am_  
  As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial team.


## arXiv q-bio

- **[Patient-specific Biomolecular Instruction Tuning](https://arxiv.org/abs/2509.22853)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.22853v1 Announce Type: new 
Abstract: Proteomics data is essential to pathogenic understanding of a disease phenotype. In cancer, analysis of molecular signatures enables precision medicine through the identification of biological processes that drive individualized tumor progression, therapeutic resistance‚Ä¶

- **[Beyond the Clinic: A Large-Scale Evaluation of Augmenting EHR with Wearable Data for Diverse Health Prediction](https://arxiv.org/abs/2509.22920)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.22920v1 Announce Type: new 
Abstract: Electronic health records (EHRs) provide a powerful basis for predicting the onset of health outcomes. Yet EHRs primarily capture in-clinic events and miss aspects of daily behavior and lifestyle containing rich health information. Consumer wearables, by contrast, conti‚Ä¶

- **[Twin Peaks: Dual-Head Architecture for Structure-Free Prediction of Protein-Protein Binding Affinity and Mutation Effects](https://arxiv.org/abs/2509.22950)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.22950v1 Announce Type: new 
Abstract: We present a novel dual-head deep learning architecture for protein-protein interaction modeling that enables simultaneous prediction of binding affinity ($\Delta G$) and mutation-induced affinity changes ($\Delta\Delta G$) using only protein sequence information. Our a‚Ä¶

- **[Targeted perturbations reveal brain-like local coding axes in robustified, but not standard, ANN-based brain models](https://arxiv.org/abs/2509.23333)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23333v1 Announce Type: new 
Abstract: Artificial neural networks (ANNs) have become the de facto standard for modeling the human visual system, primarily due to their success in predicting neural responses. However, with many models now achieving similar predictive accuracy, we need a stronger criterion. He‚Ä¶

- **[Consciousness Self and Language](https://arxiv.org/abs/2509.23342)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23342v1 Announce Type: new 
Abstract: Theories of consciousness depend on data, and it needs to be appropriate data, without overwhelming confounding factors. The reports of Minimal Phenomenal Experience (MPE) in [Metzinger 2024] relate to consciousness in a state purer than everyday consciousness, which ma‚Ä¶

- **[On the effectiveness of odor-baited traps on mosquito-borne infections](https://arxiv.org/abs/2509.23397)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23397v1 Announce Type: new 
Abstract: The host's odor serves as a critical biological tracking signal in the host-seeking process of mosquitoes, and its heterogeneity significantly influences the transmission of mosquito-borne diseases. In this study, we propose a mosquito-borne disease model incorporating‚Ä¶

- **[Dyadic Neural Dynamics: Extending Representation Learning to Social Neuroscience](https://arxiv.org/abs/2509.23479)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23479v1 Announce Type: new 
Abstract: Social communication fundamentally involves at least two interacting brains, creating a unique modeling problem. We present the first application of Contrastive Embedding for Behavioral and Neural Analysis (CEBRA) to dyadic EEG hyperscanning data, extending modeling par‚Ä¶

- **[EEG-Based Framework for Reflexive and Perceptual Assessment in CLIS: Preliminary Study in Healthy Volunteers](https://arxiv.org/abs/2509.23524)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23524v1 Announce Type: new 
Abstract: Despite the general assumption that completely locked-in state (CLIS) patients remain conscious and aware of their environment, the effectiveness of brain-computer interfaces (BCIs) in facilitating communication has been limited, as reported both in the literature and i‚Ä¶

- **[Contrastive Learning Enhances Language Model Based Cell Embeddings for Low-Sample Single Cell Transcriptomics](https://arxiv.org/abs/2509.23543)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23543v1 Announce Type: new 
Abstract: Large language models (LLMs) have shown strong ability in generating rich representations across domains such as natural language processing and generation, computer vision, and multimodal learning. However, their application in biomedical data analysis remains nascent.‚Ä¶

- **[A Computational Perspective on NeuroAI and Synthetic Biological Intelligence](https://arxiv.org/abs/2509.23896)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23896v1 Announce Type: new 
Abstract: NeuroAI is an emerging field at the intersection of neuroscience and artificial intelligence, where insights from brain function guide the design of intelligent systems. A central area within this field is synthetic biological intelligence (SBI), which combines the adap‚Ä¶

- **[Population genetics in complex ecological communities](https://arxiv.org/abs/2509.23977)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23977v1 Announce Type: new 
Abstract: Ecological interactions can dramatically alter evolutionary outcomes in complex communities. Yet, the classic theoretical results of population genetics (e.g., Kimura's fixation formula) largely ignore ecological effects. Here, we address this shortcoming by using dynam‚Ä¶

- **[End-to-end Topographic Auditory Models Replicate Signatures of Human Auditory Cortex](https://arxiv.org/abs/2509.24039)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24039v1 Announce Type: new 
Abstract: The human auditory cortex is topographically organized. Neurons with similar response properties are spatially clustered, forming smooth maps for acoustic features such as frequency in early auditory areas, and modular regions selective for music and speech in higher-or‚Ä¶

- **[LAMP-PRo: Label-aware Attention for Multi-label Prediction of DNA- and RNA-binding Proteins using Protein Language Models](https://arxiv.org/abs/2509.24262)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24262v1 Announce Type: new 
Abstract: Identifying DNA- (DBPs) and RNA-binding proteins (RBPs) is crucial for the understanding of cell function, molecular interactions as well as regulatory functions. Owing to their high similarity, most of the existing approaches face challenges in differentiating between‚Ä¶

- **[The role of viral dynamics and infectivity in models of oncolytic virotherapy for tumours with different motility](https://arxiv.org/abs/2509.24522)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24522v1 Announce Type: new 
Abstract: The use of ad-hoc engineered viruses in the fight against tumours is one of the greatest ideas in cancer therapeutics within the last three decades. Together with other strategies such as immunotherapies, nanoparticles and adjunct therapies, the use of viral vectors in‚Ä¶

- **[Brain Harmony: A Multimodal Foundation Model Unifying Morphology and Function into 1D Tokens](https://arxiv.org/abs/2509.24693)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24693v1 Announce Type: new 
Abstract: We present Brain Harmony (BrainHarmonix), the first multimodal brain foundation model that unifies structural morphology and functional dynamics into compact 1D token representations. The model was pretrained on two of the largest neuroimaging datasets to date, encompas‚Ä¶

- **[Dark Signals in the Brain: Augment Brain Network Dynamics to the Complex-valued Field](https://arxiv.org/abs/2509.24715)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24715v1 Announce Type: new 
Abstract: Recordings of brain activity, such as functional MRI (fMRI), provide low-dimensional, indirect observations of neural dynamics evolving in high-dimensional, unobservable spaces. Embedding observed brain dynamics into a higher-dimensional representation may help reveal f‚Ä¶

- **[Bifurcations and multistability in inducible three-gene toggle switch networks](https://arxiv.org/abs/2509.24926)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24926v1 Announce Type: new 
Abstract: Control of transcription presides over a vast array of biological processes including through gene regulatory circuits that exhibit multistability. Two- and three-gene network motifs are often found to be critical parts of the repertoire of metabolic and developmental p‚Ä¶

- **[De novo peptide sequencing rescoring and FDR estimation with Winnow](https://arxiv.org/abs/2509.24952)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24952v1 Announce Type: new 
Abstract: Machine learning has markedly advanced de novo peptide sequencing (DNS) for mass spectrometry-based proteomics. DNS tools offer a reliable way to identify peptides without relying on reference databases, extending proteomic analysis and unlocking applications into less-‚Ä¶

- **[Fire severity and recovery across Europe: insights from forest diversity and landscape metrics](https://arxiv.org/abs/2509.24953)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24953v1 Announce Type: new 
Abstract: In recent decades, European forests have faced an increased incidence of fire disturbances. This phenomenon is likely to persist, given the rising frequency of extreme events expected in the future. Estimating canopy recovery time after disturbance serves as a critical‚Ä¶

- **[Effectiveness and Safety of Selective IL-23 Receptor Antagonists in Moderate to Severe Ulcerative Colitis: A Systematic Review, Meta-Analysis and Trial Sequential Analysis](https://arxiv.org/abs/2509.25069)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.25069v1 Announce Type: new 
Abstract: Selective interleukin-23 receptor antagonists (IL-23RA) show promise for treating moderate to severe ulcerative colitis (UC) but their efficacy and safety are not fully understood. We performed a systematic review and meta-analysis of randomized controlled trials compar‚Ä¶

- **[Design principles of the cytotoxic CD8+ T-cell response](https://arxiv.org/abs/2509.22997)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.22997v1 Announce Type: cross 
Abstract: Cytotoxic T lymphocytes eliminate infected or malignant cells, safeguarding surrounding tissues. Although experimental and systems-immunology studies have cataloged many molecular and cellular actors involved in an immune response, the design principles governing how‚Ä¶

- **[Estimating the strength and timing of syntactic structure building in naturalistic reading](https://arxiv.org/abs/2509.23195)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23195v1 Announce Type: cross 
Abstract: A central question in psycholinguistics is the timing of syntax in sentence processing. Much of the existing evidence comes from violation paradigms, which conflate two separable processes - syntactic category detection and phrase structure construction - and implicit‚Ä¶

- **[ABConformer: Physics-inspired Sliding Attention for Antibody-Antigen Interface Prediction](https://arxiv.org/abs/2509.23254)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23254v1 Announce Type: cross 
Abstract: Accurate prediction of antibody-antigen (Ab-Ag) interfaces is critical for vaccine design, immunodiagnostics, and therapeutic antibody development. However, achieving reliable predictions from sequences alone remains a challenge. In this paper, we present ABCONFORMER,‚Ä¶

- **[Fusing Sequence Motifs and Pan-Genomic Features: Antimicrobial Resistance Prediction using an Explainable Lightweight 1D CNN-XGBoost Ensemble](https://arxiv.org/abs/2509.23552)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23552v1 Announce Type: cross 
Abstract: Antimicrobial Resistance (AMR) is a rapidly escalating global health crisis. While genomic sequencing enables rapid prediction of resistance phenotypes, current computational methods have limitations. Standard machine learning models treat the genome as an unordered c‚Ä¶

- **[Brain-language fusion enables interactive neural readout and in-silico experimentation](https://arxiv.org/abs/2509.23941)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23941v1 Announce Type: cross 
Abstract: Large language models (LLMs) have revolutionized human-machine interaction, and have been extended by embedding diverse modalities such as images into a shared language space. Yet, neural decoding has remained constrained by static, non-interactive methods. We introdu‚Ä¶

- **[Efficient Identification of High Similarity Clusters in Polygon Datasets](https://arxiv.org/abs/2509.23942)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.23942v1 Announce Type: cross 
Abstract: Advancements in tools like Shapely 2.0 and Triton can significantly improve the efficiency of spatial similarity computations by enabling faster and more scalable geometric operations. However, for extremely large datasets, these optimizations may face challenges due‚Ä¶

- **[TeraAgent: A Distributed Agent-Based Simulation Engine for Simulating Half a Trillion Agents](https://arxiv.org/abs/2509.24063)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24063v1 Announce Type: cross 
Abstract: Agent-based simulation is an indispensable paradigm for studying complex systems. These systems can comprise billions of agents, requiring the computing resources of multiple servers to simulate. Unfortunately, the state-of-the-art platform, BioDynaMo, does not scale‚Ä¶

- **[Controlling sternness in judging a good person who helps the bad](https://arxiv.org/abs/2509.24614)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24614v1 Announce Type: cross 
Abstract: Recent studies on indirect reciprocity with private assessment on complete graphs suggest the possibility that one can continuously modulate the degree of segregation by controlling how to judge a good person helping a bad one. A well-known social norm called L6 judge‚Ä¶

- **[HyperHELM: Hyperbolic Hierarchy Encoding for mRNA Language Modeling](https://arxiv.org/abs/2509.24655)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24655v1 Announce Type: cross 
Abstract: Language models are increasingly applied to biological sequences like proteins and mRNA, yet their default Euclidean geometry may mismatch the hierarchical structures inherent to biological data. While hyperbolic geometry provides a better alternative for accommodatin‚Ä¶

- **[Griffiths phase emerging from strong mutualistic disorder in high-dimensional interacting systems](https://arxiv.org/abs/2509.24692)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24692v1 Announce Type: cross 
Abstract: The majority of analysis of interacting systems is done for weak and well-balanced interactions, when in fact topology and rare event factors often result in strong and sign-biased interactions when considering real systems. We analyse the impact of strong mutualistic‚Ä¶

- **[MarS-FM: Generative Modeling of Molecular Dynamics via Markov State Models](https://arxiv.org/abs/2509.24779)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24779v1 Announce Type: cross 
Abstract: Molecular Dynamics (MD) is a powerful computational microscope for probing protein functions. However, the need for fine-grained integration and the long timescales of biomolecular events make MD computationally expensive. To address this, several generative models ha‚Ä¶

- **[Meta-Learning Theory-Informed Inductive Biases using Deep Kernel Gaussian Processes](https://arxiv.org/abs/2509.24919)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24919v1 Announce Type: cross 
Abstract: Normative and task-driven theories offer powerful top-down explanations for biological systems, yet the goals of quantitatively arbitrating between competing theories, and utilizing them as inductive biases to improve data-driven fits of real biological datasets are p‚Ä¶

- **[Is Sequence Information All You Need for Bayesian Optimization of Antibodies?](https://arxiv.org/abs/2509.24933)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24933v1 Announce Type: cross 
Abstract: Bayesian optimization is a natural candidate for the engineering of antibody therapeutic properties, which is often iterative and expensive. However, finding the optimal choice of surrogate model for optimization over the highly structured antibody space is difficult,‚Ä¶

- **[A minimal model of self-organized clusters with phase transitions in ecological communities](https://arxiv.org/abs/2509.24985)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.24985v1 Announce Type: cross 
Abstract: In complex ecological communities, species may self-organize into clusters or clumps where highly similar species can coexist. The emergence of such species clusters can be captured by the interplay between neutral and niche theories. Based on the generalized Lotka-Vo‚Ä¶

- **[FusionDTI: Fine-grained Binding Discovery with Token-level Fusion for Drug-Target Interaction](https://arxiv.org/abs/2406.01651)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2406.01651v4 Announce Type: replace 
Abstract: Predicting drug-target interaction (DTI) is critical in the drug discovery process. Despite remarkable advances in recent DTI models through the integration of representations from diverse drug and target encoders, such models often struggle to capture the fine-grai‚Ä¶

- **[Token-Level Guided Discrete Diffusion for Membrane Protein Design](https://arxiv.org/abs/2410.16735)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2410.16735v2 Announce Type: replace 
Abstract: Reparameterized diffusion models (RDMs) have recently matched autoregressive methods in protein generation, motivating their use for challenging tasks such as designing membrane proteins, which possess interleaved soluble and transmembrane (TM) regions. We introduce‚Ä¶

- **[Improving the adaptive and continuous learning capabilities of artificial neural networks: Lessons from multi-neuromodulatory dynamics](https://arxiv.org/abs/2501.06762)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2501.06762v2 Announce Type: replace 
Abstract: Continuous, adaptive learning-the ability to adapt to the environment and improve performance-is a hallmark of both natural and artificial intelligence. Biological organisms excel in acquiring, transferring, and retaining knowledge while adapting to dynamic environm‚Ä¶

- **[Depolarization block induction via slow NaV1.1 inactivation in Dravet syndrome](https://arxiv.org/abs/2505.03919)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2505.03919v2 Announce Type: replace 
Abstract: Dravet syndrome is a developmental and epileptic encephalopathy, characterized by the early onset of drug-resistant seizures and various comorbidities. Most cases of this severe and complex pathology are due to mutations of NaV1.1, a sodium channel mainly expressed‚Ä¶

- **[BrainPath: Generating Subject-Specific Brain Aging Trajectories](https://arxiv.org/abs/2508.16667)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2508.16667v2 Announce Type: replace 
Abstract: Quantifying and forecasting individual brain aging trajectories is critical for understanding neurodegenerative disease and the heterogeneity of aging, yet current approaches remain limited. Most models predict chronological age, an imperfect surrogate for biologica‚Ä¶

- **[A Sensitivity Analysis Methodology for Rule-Based Stochastic Chemical Systems](https://arxiv.org/abs/2509.17594)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.17594v2 Announce Type: replace 
Abstract: In this study, we introduce a sensitivity analysis methodology for stochastic systems in chemistry, where dynamics are often governed by random processes. Our approach is based on gradient estimation via finite differences, averaging simulation outcomes, and analyzi‚Ä¶

- **[A mean-field theory for heterogeneous random growth with redistribution](https://arxiv.org/abs/2503.23189)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2503.23189v2 Announce Type: replace-cross 
Abstract: We study the competition between random multiplicative growth and redistribution/migration in the mean-field limit, when the number of sites is very large but finite. We find that for static random growth rates, migration should be strong enough to prevent loc‚Ä¶

- **[PDFBench: A Benchmark for De novo Protein Design from Function](https://arxiv.org/abs/2505.20346)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2505.20346v2 Announce Type: replace-cross 
Abstract: Function-guided protein design is a crucial task with significant applications in drug discovery and enzyme engineering. However, the field lacks a unified and comprehensive evaluation framework. Current models are assessed using inconsistent and limited subse‚Ä¶

- **[A Graph-in-Graph Learning Framework for Drug-Target Interaction Prediction](https://arxiv.org/abs/2507.11757)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2507.11757v2 Announce Type: replace-cross 
Abstract: Accurately predicting drug-target interactions (DTIs) is pivotal for advancing drug discovery and target validation techniques. While machine learning approaches including those that are based on Graph Neural Networks (GNN) have achieved notable success in DTI‚Ä¶

- **[Toward Efficient Spiking Transformers: Synapse Pruning Meets Synergistic Learning-Based Compensation](https://arxiv.org/abs/2508.01992)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2508.01992v3 Announce Type: replace-cross 
Abstract: As a foundational architecture of artificial intelligence models, Transformer has been recently adapted to spiking neural networks with promising performance across various tasks. However, existing spiking Transformer~(ST)-based models require a substantial nu‚Ä¶

- **[The Physical Basis of Prediction: World Model Formation in Neural Organoids via an LLM-Generated Curriculum](https://arxiv.org/abs/2509.04633)**  
  _Tue, 30 Sep 2025 00:00:00 -0400_  
  arXiv:2509.04633v2 Announce Type: replace-cross 
Abstract: The capacity of an embodied agent to understand, predict, and interact with its environment is fundamentally contingent on an internal world model. This paper introduces a novel framework for investigating the formation and adaptation of such world models with‚Ä¶
